Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

被引:32
|
作者
Han, Man-Hoon [1 ]
Lee, Jee Hyun [2 ]
Kim, Gyeonghwa [2 ]
Lee, Eunhye [2 ]
Lee, Yu Rim [3 ]
Jang, Se Young [3 ]
Lee, Hye Won [4 ]
Chun, Jae Min [5 ]
Han, Young Seok [5 ]
Yoon, Jun Sik [6 ]
Kang, Min Kyu [7 ]
Lee, Won Kee [8 ,9 ]
Kweon, Young Oh [3 ]
Tak, Won Young [3 ]
Park, Soo Young [3 ]
Park, Jung Gil [7 ]
Hur, Keun [2 ]
机构
[1] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Pathol, Daegu 41944, South Korea
[2] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Daegu 41944, South Korea
[3] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Sch Med, Dept Pathol, Daegu 42601, South Korea
[5] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu 41944, South Korea
[6] Inje Univ, Busan Paik Hosp, Dept Internal Med, Coll Med, Busan 74392, South Korea
[7] Yeungnam Univ, Coll Med, Dept Internal Med, Daegu 42415, South Korea
[8] Kyungpook Natl Univ, Med Res Collaborat Ctr KNUH, Daegu 42415, South Korea
[9] Kyungpook Natl Univ, Sch Med, Daegu 42415, South Korea
关键词
noncoding RNA; biomarker; lncRNA GAS5; nonalcoholic fatty liver disease; liver fibrosis; CANCER; HOTAIR; LINCRNA-P21; MORTALITY; MECHANISM; DIAGNOSIS; BIOMARKER; FEATURES; CELLS;
D O I
10.3390/genes11050545
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Advanced liver fibrosis is the most important prognostic factor in nonalcoholic fatty liver disease (NAFLD). The long noncoding RNA (lncRNA), growth arrest-specific transcript 5 (GAS5), is associated with the inhibition of liver fibrogenesis, and its levels are decreased in cirrhotic liver. Methods: We analyzed 51 patients with NAFLD, the diagnosis of which was confirmed by liver biopsy. Expression of GAS5 in both the liver and plasma of the patients was analyzed using a quantitative real-time polymerase chain reaction according to the fibrosis stage. Results: Plasma GAS5 expression was significantly higher in patients with advanced fibrosis than in those without. As the fibrosis progressed, GAS5 expression in plasma increased, with the exception of that in cirrhotic livers. Plasma levels of GAS5 were lower in patients with cirrhosis than in those with advanced fibrosis. Conclusion: Elevated circulating levels of the lncRNA GAS5 are associated with the progression of liver fibrosis prior to the development of cirrhosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Expression of Liver X Receptor Correlates with Intrahepatic Inflammation and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Ahn, Sang Bong
    Jang, Kiseok
    Jun, Dae Won
    Lee, Byung Hoon
    Shin, Kye Jung
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (12) : 2975 - 2982
  • [2] Expression of Liver X Receptor Correlates with Intrahepatic Inflammation and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
    Sang Bong Ahn
    Kiseok Jang
    Dae Won Jun
    Byung Hoon Lee
    Kye Jung Shin
    Digestive Diseases and Sciences, 2014, 59 : 2975 - 2982
  • [3] Role of Noncoding RNA in Development of Nonalcoholic Fatty Liver Disease
    Huang, Ruixian
    Duan, Xiaoyan
    Fan, Jangao
    Li, Guangming
    Wang, Baocan
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [4] ALTERED EXPRESSION OF LONG NONCODING RNA GAS5 IN OSTEOPOROTIC PATIENTS SERUM
    Visconti, V. V.
    Fittipaldi, S.
    Ciuffi, S.
    Fontana, L.
    Brandi, M. L.
    Tarantino, U.
    Botta, A.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S323 - S323
  • [5] Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment
    De Vincentis, Antonio
    Rahmani, Zahra
    Muley, Moises
    Vespasiani-Gentilucci, Umberto
    Ruggiero, Sergio
    Zamani, Parvin
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    DRUG DISCOVERY TODAY, 2020, 25 (07) : 1277 - 1286
  • [6] Cognitive impairment in patients with nonalcoholic fatty liver disease with liver fibrosis
    Celikbilek, Asuman
    Celikbilek, Mehmet
    LIVER INTERNATIONAL, 2020, 40 (05) : 1239 - 1239
  • [7] Evaluation of fibrosis in patients with nonalcoholic fatty liver disease
    Montano-Loza, Aldo J.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2022, 87 (01): : 1 - 3
  • [8] ARTERIAL STIFFNESS CORRELATES WITH THE SEVERITY OF HEPATIC FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Boutari, Chrysoula
    Tziomalos, Konstantinos
    Lefkos, Petros
    Doumas, Michael
    Athyros, Vasilios
    Karagiannis, Asterios
    ATHEROSCLEROSIS, 2017, 263 : E197 - E197
  • [9] LONG-ACTING INSULIN IS ASSOCIATED WITH PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Seo, Dong Joo
    Lee, David
    Rai, Puja
    Zelman, Sara
    Fan, Gregory Hongyuan
    Malik, Raza
    HEPATOLOGY, 2020, 72 : 1053 - 1053
  • [10] The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease
    Xiaoxiao Ge
    Tao Sun
    Yanmei Zhang
    Yongqing Li
    Peng Gao
    Dantong Zhang
    Bingyang Zhang
    Peijun Wang
    Wanshan Ma
    Sumei Lu
    Nutrition & Metabolism, 19